82 FR 35216 - Fostering Medical Innovation: A Plan for Digital Health Devices; Software Precertification Pilot Program
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration Federal Register Volume 82, Issue 144 (July 28, 2017)
Food and Drug Administration
Federal Register Volume 82, Issue 144 (July 28, 2017)
| Page Range | 35216-35218 | |
| FR Document | 2017-15891 |
[Federal Register Volume 82, Number 144 (Friday, July 28, 2017)] [Notices] [Pages 35216-35218] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-15891] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2017-N-4301] Fostering Medical Innovation: A Plan for Digital Health Devices; Software Precertification Pilot Program AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration's (FDA, the Agency, or we) Center for Devices and Radiological Health (CDRH or Center) is announcing its Software Precertification Pilot Program. The program aims to evaluate a new approach toward software products, including a precertification program for the assessment of companies that perform high-quality software design and testing. This voluntary pilot program is part of FDA's ongoing efforts to develop pragmatic approaches to balance benefits and risks of digital health products. FDA intends to develop a precertification program that could replace the need for a premarket submission in some cases and allow for decreased submission content and/or faster review of marketing applications for software products in other cases. During the pilot program, FDA customers, including pilot participants, will have the opportunity to provide input on the development of the precertification program. DATES: FDA is seeking participation in the voluntary Software Precertification pilot program beginning August 1, 2017. See the ``Participation'' section for instructions on how to submit a request to participate. The voluntary Software Precertification pilot program will select up to nine participants who best match the selection criteria. This pilot program will begin September 1, 2017. ADDRESSES: You may submit comments as follows: Electronic Submissions Submit electronic comments in the following way:Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ``Written/Paper Submissions'' and ``Instructions''). Written/Paper Submissions Submit written/paper submissions as follows: Mail/Hand delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ``Instructions.'' Instructions: All submissions received must include the Docket No. FDA-2017-N-4301 for ``Fostering Medical Innovation: A Plan for Digital Health Devices; Software Precertification Pilot Program.'' Received comments will be placed in the docket and, except for those submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday. Confidential Submissions--To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ``confidential.'' Any information marked as ``confidential'' will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.thefederalregister.org/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ``Search'' box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Bakul Patel, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5458, Silver Spring, MD 20993, 301-796-5528, [email protected]. SUPPLEMENTARY INFORMATION: I. Background FDA recognizes that an efficient, risk-based approach to regulating digital health technology will foster innovation of digital health products. FDA's traditional approach to moderate and higher risk hardware-based medical devices is not well suited for the faster iterative design, development, and type of validation used for software products. An agile paradigm is necessary to accommodate the faster rate of development and innovation of software devices as compared to other types of devices. Traditional implementation of the premarket requirements may impede or delay patient access to critical evolutions of software technology, particularly those presenting a lower risk to patients. To evaluate a new approach toward software, FDA is launching a pilot of a precertification program for the assessment of companies that perform high-quality software design and testing. The Software Precertification (Pre-Cert) pilot program is part of FDA's ongoing efforts [[Page 35217]] to develop pragmatic approaches within its existing authorities to optimally foster the development of high-quality, safe and effective digital health products while assuring timely patient access. FDA has previously discussed the idea of a precertification program in various forums and invites further input from all stakeholders throughout this pilot. FDA intends to establish a process for company precertification that could replace the need for a premarket submission for certain products or allow for decreased submission content and/or faster review of marketing submissions for other products. CDRH plans to select its first participants and initiate the voluntary Software Pre-Cert pilot program focusing on receiving input on the activities and criteria critical to streamlining premarket review of software products by September 1, 2017. FDA is issuing its Digital Health Innovation Action Plan.\1\ The Action Plan presents FDA's vision for the regulation of digital health technologies that are medical devices and the actions FDA intends to pursue to provide greater clarity regarding what types of digital health technology are subject to regulation. In the Action Plan, FDA describes a forward-leaning approach to ensure that we will implement the right policies and regulatory tools. The Software Pre-Cert pilot program is one component of FDA's comprehensive approach to digital health medical devices described in the Action Plan. FDA welcomes comments on the policies, pathways, and regulatory tools the Agency should consider in designing a new paradigm for overseeing digital health medical devices. (See information on how to submit comments to the public docket in the ADDRESSES section.) --------------------------------------------------------------------------- \1\ Available at https://www.fda.gov/MedicalDevices/DigitalHealth/UCM567265. --------------------------------------------------------------------------- The Software Pre-Cert pilot will help inform the development of the Pre-Cert program for software developers, including what criteria can be used to assess whether a company consistently and reliably engages in high-quality software design and testing (validation) and ongoing maintenance of its software products. FDA and companies participating in the pilot program will explore the use of external software development standards to reduce premarket software documentation burden. Precertified companies that have demonstrated a culture of quality and organizational excellence could bring certain types of digital health products to market without FDA premarket review or after a streamlined, less-burdensome FDA premarket review. The criteria developed and evaluated for precertification during the pilot program may also be used to inform the establishment of a third-party certification program, in which third parties may facilitate the precertification of companies, and will enable greater patient access to digital health technologies and will allow the Agency to devote more resources to the evaluation of higher risk technologies/products. Companies are eligible to participate in this voluntary Software Pre-Cert pilot program based on the criteria listed in Section A. Participation. FDA will select up to nine participants, who best match the selection criteria and who reflect the broad spectrum of software developers (e.g., both small and large software development firms). FDA intends to include companies that develop a range of products (both low and high risk) to learn how to apply the Software Pre-Cert program to different product types. FDA also intends to include companies that are not considered to be traditional medical device manufacturers, but who intend to make digital health technology. The purpose of the Software Pre-Cert pilot is to leverage customer input to develop a program that can help reduce the time and cost of market entry for software developers that FDA determines reliably manufacture high-quality, safe and effective digital health devices. This voluntary pilot program does not represent a new requirement; instead, it is an opportunity to help FDA develop an innovative approach for digital health technology. A. Participation Companies that may be eligible to participate in this voluntary Software Pre-Cert pilot program are limited to those firms who follow the procedures set out in Section B and also meet the following selection qualities that follow. 1. The company must be developing or planning to develop a software product that meets the definition of a device in section 201(h) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(h)). 2. The company has an existing track record in developing, testing, and maintaining software products demonstrating a culture of quality and organizational excellence measured and tracked by Key Performance Indicators (KPIs) or other similar measures. 3. While participating in the pilot, the company must agree to: a. Provide access to measures described in selection quality number 2, listed previously (KPIs or similar measures). b. Collect real-world postmarket performance data and provide it to FDA. c. Be available for real-time consultations with FDA. d. Be available for site visits from FDA officials. e. Provide information about the firm's quality management system. B. Procedures To be considered for the voluntary Software Pre-Cert pilot program, a company should submit a statement of interest for participation to [email protected]. The statement of interest should include agreement to the selection qualities listed in Section A. Participation. The following captures the proposed process for the voluntary Software Pre-Cert pilot program: 1. FDA will collect statements of interest for participation in the pilot program beginning August 1, 2017. 2. FDA will evaluate the statements of interest for participation and select no more than nine participants, who best meet the selection criteria and who reflect the broad spectrum of software developers, including companies that develop a range of products (both low and high risk). FDA will work with the selected participants to develop criteria for precertification and the types of information that should be reviewed during the precertification process or postmarket, rather than during the review of a premarket submission. a. Depending on the stage of development of the company's software product, FDA will work interactively with the participating company through the Q-submission process, including via Pre-Submissions, Informational Meetings, Submission Issue Meetings, etc. (Ref. 1). 3. Enrollment in the pilot program will be ongoing throughout the duration of the program. FDA will apply lessons learned from the initial participants in the pilot program to refine the precertification program in collaboration with participants. During this voluntary Software Pre-Cert pilot program, CDRH staff intends to be available to answer questions or concerns that may arise. The voluntary Software Pre-Cert pilot program participants will be asked to comment on and discuss their experiences with the Software Pre-Cert pilot process. II. Beginning Date of the Software Pre-Cert Pilot Program FDA intends to accept requests for participation in the voluntary Software Pre-Cert pilot program beginning August 1, 2017. This pilot program will begin September 1, 2017. [[Page 35218]] III. Paperwork Reduction Act of 1995 This notice refers to previously approved collections of information found in FDA regulations. These collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The collections of information in 21 CFR part 807, subpart E have been approved under OMB control number 0910-0120; the collections of information in 21 CFR part 814, subparts A through E have been approved under OMB control number 0910-0231; the collections of information in 21 CFR part 820 have been approved under OMB control number 0910-0073; and the collections of information in ``Requests for Feedback on Medical Device Submissions: The Pre-Submission Program and Meetings with Food and Drug Administration Staff'' have been approved under OMB control number 0910-0756. IV. Reference The following reference is on display in the Dockets Management Staff (see ADDRESSES) and is available for viewing by interested persons between 9 a.m. and 4 p.m., Monday through Friday; it is also available electronically at https://www.regulations.gov. FDA has verified the Web site address, as of the date this document publishes in the Federal Register, but Web sites are subject to change over time. 1. ``Requests for Feedback on Medical Device Submissions: The Pre- Submission Program and Meetings with Food and Drug Administration Staff; Guidance for Industry and Food and Drug Administration Staff,'' February 2014, available at https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-meddev-gen/documents/document/ucm311176.pdf. Dated: July 24, 2017. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2017-15891 Filed 7-27-17; 8:45 am] BILLING CODE 4164-01-P
![35216 Federal Register / Vol. 82, No. 144 / Friday, July 28, 2017 / Notices
Dated: July 24, 2017. Comments submitted electronically, claimed confidential information
Anna K. Abram, including attachments, to https:// redacted/blacked out, will be available
Deputy Commissioner for Policy, Planning, www.regulations.gov will be posted to for public viewing and posted on
Legislation, and Analysis. the docket unchanged. Because your https://www.regulations.gov. Submit
[FR Doc. 2017–15900 Filed 7–27–17; 8:45 am] comment will be made public, you are both copies to the Dockets Management
BILLING CODE 4164–01–P solely responsible for ensuring that your Staff. If you do not wish your name and
comment does not include any contact information to be made publicly
confidential information that you or a available, you can provide this
DEPARTMENT OF HEALTH AND third party may not wish to be posted, information on the cover sheet and not
HUMAN SERVICES such as medical information, your or in the body of your comments and you
anyone else’s Social Security number, or must identify this information as
Food and Drug Administration confidential business information, such ‘‘confidential.’’ Any information marked
as a manufacturing process. Please note as ‘‘confidential’’ will not be disclosed
[Docket No. FDA–2017–N–4301]
that if you include your name, contact except in accordance with 21 CFR 10.20
Fostering Medical Innovation: A Plan information, or other information that and other applicable disclosure law. For
for Digital Health Devices; Software identifies you in the body of your more information about FDA’s posting
Precertification Pilot Program comments, that information will be of comments to public dockets, see 80
posted on https://www.regulations.gov. FR 56469, September 18, 2015, or access
AGENCY: Food and Drug Administration, • If you want to submit a comment the information at: https://www.gpo.gov/
HHS. with confidential information that you fdsys/pkg/FR-2015-09-18/pdf/2015-
ACTION: Notice. do not wish to be made available to the 23389.pdf.
public, submit the comment as a Docket: For access to the docket to
SUMMARY: The Food and Drug written/paper submission and in the read background documents or the
Administration’s (FDA, the Agency, or manner detailed (see ‘‘Written/Paper electronic and written/paper comments
we) Center for Devices and Radiological Submissions’’ and ‘‘Instructions’’). received, go to https://
Health (CDRH or Center) is announcing www.regulations.gov and insert the
Written/Paper Submissions
its Software Precertification Pilot docket number, found in brackets in the
Program. The program aims to evaluate Submit written/paper submissions as heading of this document, into the
a new approach toward software follows: ‘‘Search’’ box and follow the prompts
products, including a precertification • Mail/Hand delivery/Courier (for
and/or go to the Dockets Management
program for the assessment of written/paper submissions): Dockets
Staff, 5630 Fishers Lane, Rm. 1061,
companies that perform high-quality Management Staff (HFA–305), Food and
Rockville, MD 20852.
software design and testing. This Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT:
voluntary pilot program is part of FDA’s
ongoing efforts to develop pragmatic • For written/paper comments Bakul Patel, Center for Devices and
submitted to the Dockets Management Radiological Health, Food and Drug
approaches to balance benefits and risks Administration, 10903 New Hampshire
of digital health products. FDA intends Staff, FDA will post your comment, as
well as any attachments, except for Ave., Bldg. 66, Rm. 5458, Silver Spring,
to develop a precertification program MD 20993, 301–796–5528, Bakul.Patel@
that could replace the need for a information submitted, marked and
identified, as confidential, if submitted fda.hhs.gov.
premarket submission in some cases
as detailed in ‘‘Instructions.’’ SUPPLEMENTARY INFORMATION:
and allow for decreased submission
content and/or faster review of Instructions: All submissions received
I. Background
marketing applications for software must include the Docket No. FDA–
2017–N–4301 for ‘‘Fostering Medical FDA recognizes that an efficient, risk-
products in other cases. During the pilot
Innovation: A Plan for Digital Health based approach to regulating digital
program, FDA customers, including
Devices; Software Precertification Pilot health technology will foster innovation
pilot participants, will have the
Program.’’ Received comments will be of digital health products. FDA’s
opportunity to provide input on the
placed in the docket and, except for traditional approach to moderate and
development of the precertification
those submitted as ‘‘Confidential higher risk hardware-based medical
program.
Submissions,’’ publicly viewable at devices is not well suited for the faster
DATES: FDA is seeking participation in https://www.regulations.gov or at the iterative design, development, and type
the voluntary Software Precertification Dockets Management Staff between 9 of validation used for software products.
pilot program beginning August 1, 2017. a.m. and 4 p.m., Monday through An agile paradigm is necessary to
See the ‘‘Participation’’ section for Friday. accommodate the faster rate of
instructions on how to submit a request • Confidential Submissions—To development and innovation of software
to participate. The voluntary Software submit a comment with confidential devices as compared to other types of
Precertification pilot program will select information that you do not wish to be devices. Traditional implementation of
up to nine participants who best match made publicly available, submit your the premarket requirements may impede
the selection criteria. This pilot program comments only as a written/paper or delay patient access to critical
will begin September 1, 2017. submission. You should submit two evolutions of software technology,
asabaliauskas on DSKBBXCHB2PROD with NOTICES
ADDRESSES: You may submit comments copies total. One copy will include the particularly those presenting a lower
as follows: information you claim to be confidential risk to patients. To evaluate a new
with a heading or cover note that states approach toward software, FDA is
Electronic Submissions ‘‘THIS DOCUMENT CONTAINS launching a pilot of a precertification
Submit electronic comments in the CONFIDENTIAL INFORMATION.’’ The program for the assessment of
following way: Agency will review this copy, including companies that perform high-quality
• Federal eRulemaking Portal: the claimed confidential information, in software design and testing. The
https://www.regulations.gov. Follow the its consideration of comments. The Software Precertification (Pre-Cert) pilot
instructions for submitting comments. second copy, which will have the program is part of FDA’s ongoing efforts
VerDate Sep<11>2014 18:50 Jul 27, 2017 Jkt 241001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\28JYN1.SGM 28JYN1](https://thefederalregister.org/doc/82_FR_35360/page/1.svg)
![35218 Federal Register / Vol. 82, No. 144 / Friday, July 28, 2017 / Notices
III. Paperwork Reduction Act of 1995 Catalog of Federal Domestic community responses to American
This notice refers to previously Assistance Number (CFDA): 93.933. Indian/Alaska Native (AI/AN) victims of
approved collections of information domestic and sexual violence.
Key Dates
found in FDA regulations. These 2. Increase access to domestic and
Application Deadline Date: August sexual violence prevention, advocacy,
collections of information are subject to
31, 2017. crisis intervention, and behavioral
review by the Office of Management and Review Date: September 11, 2017.
Budget (OMB) under the Paperwork health services for AI/AN victims and
Earliest Anticipated Start Date: their families.
Reduction Act of 1995 (44 U.S.C. 3501– September 30, 2017.
3520). The collections of information in 3. Promote trauma-informed services
Signed Tribal Resolutions Due Date:
21 CFR part 807, subpart E have been for AI/AN victims of domestic and
August 31, 2017.
approved under OMB control number Proof of Non-Profit Status Due Date: sexual violence and their families.
0910–0120; the collections of August 31, 2017. 4. Offer health care provider and
information in 21 CFR part 814, community education on domestic and
subparts A through E have been I. Funding Opportunity Description sexual violence.
approved under OMB control number Statutory Authority 5. Respond to the health care needs of
0910–0231; the collections of AI/AN victims of domestic and sexual
The Indian Health Service (IHS), violence.
information in 21 CFR part 820 have Office of Clinical and Preventive
been approved under OMB control 6. Incorporate culturally appropriate
Services (OCPS), Division of Behavioral practices and/or faith-based services for
number 0910–0073; and the collections Health (DBH) is accepting applications
of information in ‘‘Requests for AI/AN victims of domestic and sexual
for a three-year funding cycle, to violence.
Feedback on Medical Device continue the planning, development,
Submissions: The Pre-Submission To accomplish the DVPI goals, IHS
and implementation of the Domestic invites applicants to address one of the
Program and Meetings with Food and Violence Prevention Initiative (DVPI).
Drug Administration Staff’’ have been Purpose Areas below:
This program was first established by
approved under OMB control number the Omnibus Appropriations Act of • Purpose Area 1: Domestic and Sexual
0910–0756. 2009, Public Law 111–8, 123 Stat. 524, Violence Prevention, Advocacy, and
735, and continued in the annual Coordinated Community Responses
IV. Reference
appropriations acts since that time. This • Purpose Area 2: Provide Forensic
The following reference is on display Health Care Services
in the Dockets Management Staff (see program is authorized under the
ADDRESSES) and is available for viewing
authority of 25 U.S.C. 13, the Snyder Evidence-Based Practices, Practice-
by interested persons between 9 a.m. Act, and the Indian Health Care Based Evidence, Promising Practices,
and 4 p.m., Monday through Friday; it Improvement Act, 25 U.S.C. 1601–1683. and Local Efforts
is also available electronically at https:// This program is described in the Catalog
of Federal Domestic Assistance under IHS strongly emphasizes the use of
www.regulations.gov. FDA has verified data and evidence in policymaking and
the Web site address, as of the date this 93.933.
program development and
document publishes in the Federal Background implementation. Applicants under each
Register, but Web sites are subject to The DBH serves as the primary source Purpose Area must identify one or more
change over time. of national advocacy, policy evidence-based practice, practice-based
1. ‘‘Requests for Feedback on Medical Device development, management and evidence, best or promising practice,
Submissions: The Pre-Submission administration of behavioral health, and/or local effort they plan to
Program and Meetings with Food and alcohol and substance abuse, and family implement in the Project Narrative
Drug Administration Staff; Guidance for section of their application. The DVPI
Industry and Food and Drug
violence prevention programs. In 2015,
DBH funded 57 Tribes, Tribal program Web site (https://www.ihs.gov/
Administration Staff,’’ February 2014,
available at https://www.fda.gov/ucm/ organizations, Urban Indian dvpi/bestpractices/) is one resource that
groups/fdagov-public/@fdagov-meddev- Organization (UIOs), and IHS federal applicants may use to find information
gen/documents/document/ facilities that participate in a nationally to build on the foundation of prior
ucm311176.pdf. coordinated project to expand outreach domestic and sexual violence
and increase awareness of domestic and prevention and treatment efforts, in
Dated: July 24, 2017. order to support the IHS, Tribes, Tribal
sexual violence and provide victim
Leslie Kux, advocacy, intervention, case organizations, and UIOs in developing
Associate Commissioner for Policy. coordination, policy development, and implementing Tribal and/or
[FR Doc. 2017–15891 Filed 7–27–17; 8:45 am] community response teams, and culturally appropriate domestic and
BILLING CODE 4164–01–P community and school education sexual violence prevention and early
programs. The DVPI promotes the intervention strategies.
development of evidence-based and Purpose Areas
DEPARTMENT OF HEALTH AND practice-based models that represent
HUMAN SERVICES culturally appropriate prevention and Purpose Area 1: Domestic and Sexual
treatment approaches to domestic and Violence Prevention, Advocacy, and
Indian Health Service Coordinated Community Responses.
asabaliauskas on DSKBBXCHB2PROD with NOTICES
sexual violence from a community-
driven context. IHS is seeking applicants to address the
Division of Behavioral Health, Office of following broad objectives:
Clinical and Preventive Services; Purpose • Expand crisis intervention,
Funding Opportunities: Domestic counseling, advocacy, behavioral health,
The primary purpose of this grant
Violence Prevention Initiative and case management services to
program is to accomplish the DVPI goals
Announcement Type: New. listed below: victims of domestic and sexual violence;
Funding Announcement Number: 1. Build Tribal, UIO, and Federal • Foster coalitions and networks to
HHS–2017–IHS–DVPI–0001. capacity to provide coordinated improve coordination and collaboration
VerDate Sep<11>2014 18:50 Jul 27, 2017 Jkt 241001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\28JYN1.SGM 28JYN1](https://thefederalregister.org/doc/82_FR_35360/page/3.svg)
Document Created: 2017-07-28 03:09:54
Document Modified: 2017-07-28 03:09:54
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | FDA is seeking participation in the voluntary Software Precertification pilot program beginning August 1, 2017. See the ``Participation'' section for instructions on how to submit a request to participate. The voluntary Software Precertification pilot program will select up to nine participants who best match the selection criteria. This pilot program will begin September 1, 2017. | |
| Contact | Bakul Patel, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5458, Silver Spring, MD 20993, 301-796-5528, [email protected] | |
| FR Citation | 82 FR 35216 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR